Bank of Montreal’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $64.4M | Buy |
103,247
+17,723
| +21% | +$12.1M | 0.02% | 521 |
|
|
2026
Q1 | $66.1M | Sell |
85,524
-15,453
| -15% | -$11.8M | 0.02% | 468 |
|
|
2025
Q4 | $77.9M | Buy |
100,977
+4,708
| +5% | +$3.2M | 0.03% | 425 |
|
|
2025
Q3 | $54.1M | Sell |
96,269
-28,327
| -23% | -$16M | 0.02% | 470 |
|
|
2025
Q2 | $65.4M | Buy |
124,596
+10,832
| +10% | +$6.05M | 0.03% | 363 |
|
|
2025
Q1 | $72.2M | Sell |
113,764
-39,503
| -26% | -$27.2M | 0.04% | 332 |
|
|
2024
Q4 | $109M | Sell |
153,267
-34,890
| -19% | -$29.3M | 0.05% | 270 |
|
|
2024
Q3 | $196M | Buy |
188,157
+2,866
| +2% | +$3.19M | 0.09% | 183 |
|
|
2024
Q2 | $200M | Sell |
185,291
-43,762
| -19% | -$42.4M | 0.06% | 175 |
|
|
2024
Q1 | $222M | Sell |
229,053
-56,112
| -20% | -$53.4M | 0.07% | 166 |
|
|
2023
Q4 | $253M | Buy |
285,165
+104,050
| +57% | +$85.7M | 0.08% | 149 |
|
|
2023
Q3 | $151M | Buy |
181,115
+33,317
| +23% | +$26.2M | 0.05% | 198 |
|
|
2023
Q2 | $117M | Buy |
147,798
+61,509
| +71% | +$47.4M | 0.04% | 233 |
|
|
2023
Q1 | $70.9M | Sell |
86,289
-23,814
| -22% | -$18M | 0.03% | 297 |
|
|
2022
Q4 | $80.8M | Buy |
110,103
+38,901
| +55% | +$28.7M | 0.04% | 281 |
|
|
2022
Q3 | $49.8K | Sell |
71,202
-55,551
| -44% | -$35M | 0.02% | 370 |
|
|
2022
Q2 | $76.4K | Buy |
126,753
+38,662
| +44% | +$25.1M | 0.04% | 294 |
|
|
2022
Q1 | $61.3M | Sell |
88,091
-35,419
| -29% | -$22.4M | 0.03% | 398 |
|
|
2021
Q4 | $80.3M | Sell |
123,510
-35,725
| -22% | -$22M | 0.04% | 316 |
|
|
2021
Q3 | $97.2M | Buy |
159,235
+31,248
| +24% | +$19.4M | 0.04% | 350 |
|
|
2021
Q2 | $70M | Buy |
127,987
+29,131
| +29% | +$14.8M | 0.03% | 412 |
|
|
2021
Q1 | $47.1M | Sell |
98,856
-20,207
| -17% | -$9.84M | 0.03% | 418 |
|
|
2020
Q4 | $59.9M | Buy |
119,063
+22,468
| +23% | +$12.1M | 0.04% | 371 |
|
|
2020
Q3 | $56.2M | Buy |
96,595
+94
| +0.1% | +$57K | 0.05% | 322 |
|
|
2020
Q2 | $61.8M | Buy |
96,501
+48,956
| +103% | +$27.8M | 0.06% | 284 |
|
|
2020
Q1 | $23.7M | Sell |
47,545
-15,635
| -25% | -$6.45M | 0.03% | 448 |
|
|
2019
Q4 | $23.7M | Buy |
63,180
+6,130
| +11% | +$2.06M | 0.02% | 636 |
|
|
2019
Q3 | $15.8M | Buy |
57,050
+7,914
| +16% | +$2.34M | 0.01% | 702 |
|
|
2019
Q2 | $15.4M | Sell |
49,136
-7,606
| -13% | -$2.53M | 0.01% | 730 |
|
|
2019
Q1 | $23.3M | Buy |
56,742
+14,540
| +34% | +$5.99M | 0.02% | 556 |
|
|
2018
Q4 | $15.8M | Sell |
42,202
-13,195
| -24% | -$4.83M | 0.01% | 631 |
|
|
2018
Q3 | $22.4M | Buy |
55,397
+11,943
| +27% | +$4.55M | 0.02% | 604 |
|
|
2018
Q2 | $15M | Sell |
43,454
-94,919
| -69% | -$29.7M | 0.01% | 717 |
|
|
2018
Q1 | $47.7M | Sell |
138,373
-50,455
| -27% | -$17.5M | 0.04% | 373 |
|
|
2017
Q4 | $71M | Buy |
188,828
+146,147
| +342% | +$59.2M | 0.06% | 285 |
|
|
2017
Q3 | $19.1M | Buy |
42,681
+267
| +0.6% | +$127K | 0.02% | 608 |
|
|
2017
Q2 | $20.8M | Sell |
42,414
-8,405
| -17% | -$3.68M | 0.02% | 577 |
|
|
2017
Q1 | $19.7M | Buy |
50,819
+18,030
| +55% | +$6.68M | 0.02% | 562 |
|
|
2016
Q4 | $12.4M | Buy |
32,789
+1,395
| +4% | +$530K | 0.01% | 725 |
|
|
2016
Q3 | $12.6M | Sell |
31,394
-4,819
| -13% | -$1.93M | 0.01% | 719 |
|
|
2016
Q2 | $12.6M | Sell |
36,213
-2,836
| -7% | -$1.09M | 0.01% | 706 |
|
|
2016
Q1 | $14.1M | Sell |
39,049
-2,895
| -7% | -$1.19M | 0.02% | 609 |
|
|
2015
Q4 | $22.8M | Buy |
41,944
+1,933
| +5% | +$1.05M | 0.03% | 435 |
|
|
2015
Q3 | $18.6M | Sell |
40,011
-2,063
| -5% | -$1.11M | 0.03% | 483 |
|
|
2015
Q2 | $21.5M | Buy |
42,074
+5,165
| +14% | +$2.52M | 0.03% | 496 |
|
|
2015
Q1 | $16.7M | Buy |
36,909
+2,078
| +6% | +$881K | 0.02% | 578 |
|
|
2014
Q4 | $14.3M | Sell |
34,831
-47,545
| -58% | -$18.7M | 0.02% | 627 |
|
|
2014
Q3 | $29.7M | Buy |
82,376
+55,265
| +204% | +$18.5M | 0.03% | 388 |
|
|
2014
Q2 | $7.66M | Buy |
27,111
+10,661
| +65% | +$3.16M | 0.01% | 926 |
|
|
2014
Q1 | $4.94M | Buy |
16,450
+3,459
| +27% | +$1.07M | 0.01% | 945 |
|
|
2013
Q4 | $3.58M | Buy |
12,991
+1,475
| +13% | +$424K | ﹤0.01% | 958 |
|
|
2013
Q3 | $3.6M | Sell |
11,516
-22,941
| -67% | -$6.03M | 0.01% | 901 |
|
|
2013
Q2 | $7.75M | Buy |
+34,457
| New | +$8.02M | 0.01% | 577 |
|
Other funds holding REGN
VCM
VPM
N
Bank of Montreal's REGN Position: Q2 2026 in Review
Bank of Montreal increased its Regeneron Pharmaceuticals (REGN) stake by 21% in Q2 2026, buying an estimated $12.1M and bringing the position to 103,247 shares worth $64.4M. The position accounts for 0.02% of the portfolio, ranked #521.
Bank of Montreal first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $253M in Q4 2023. 1,085 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Bank of Montreal held 103,247 shares of Regeneron Pharmaceuticals worth $64.4M as of Q2 2026.
- Bank of Montreal bought 17,723 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $12.1M.
- Regeneron Pharmaceuticals made up 0.02% of Bank of Montreal's portfolio in Q2 2026, its #521 holding.
- Bank of Montreal first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Bank of Montreal's Regeneron Pharmaceuticals position peaked at $253M in Q4 2023.
- 1,085 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.